SCREENER PRESET · LIVE FROM NSE/BSE FILINGS

Small-cap growth stocks in India

Small-cap Indian companies (₹500–5,000 Cr market cap) growing revenue above 25% YoY with positive profit growth. High-risk, high-potential universe — filter before research.

28 MATCHED

Mcap ≥ ₹500 Cr · Mcap ≤ ₹5000 Cr · Rev growth ≥ 25% · Profit growth ≥ 10%

Symbol	Sector	Mkt cap (Cr)	P/E	ROE %	ROCE %	D/E	Rev YoY
JPOLYINVST	Other	1,195	1.3	54.3%	—	0.01	+12230.9%
NBIFIN	Other	643	42.1	0.5%	—	—	+1427.9%
ARROWGREEN	Other	826	16.0	24.3%	—	0.01	+132.1%
JNKINDIA	Other	1,884	41.1	8.4%	—	0.05	+116.7%
MBAPL	Other	4,559	43.5	22.9%	—	0.68	+115.8%
ARVSMART	Other	2,729	37.4	12.2%	—	0.21	+109.1%
MENONBE	Other	695	22.3	19.6%	—	0.33	+95.9%
MODIS	Other	660	26.5	23.6%	—	—	+70.0%
KPEL	Other	2,353	15.7	39.2%	—	1.22	+62.9%
KRISHANA	Other	3,949	30.4	38.1%	—	1.31	+59.8%
NILASPACES	Other	540	22.4	15.5%	—	0.63	+58.1%
KMEW	Other	4,156	60.7	25.2%	—	0.60	+56.3%
JYOTISTRUC	Other	1,576	30.0	10.3%	—	3.85	+52.1%
NAVKARCORP	Other	1,686	—	-0.1%	—	0.09	+43.4%
MACPOWER	Other	1,121	34.7	20.9%	—	0.01	+43.3%
NGLFINE	Other	1,423	40.2	11.8%	—	0.29	+43.1%
EMUDHRA	Other	4,230	41.5	12.5%	—	0.02	+39.2%
MVGJL	Other	862	7.6	14.7%	—	0.53	+37.6%
LAXMIINDIA	Other	638	14.6	9.5%	—	2.56	+37.0%
KRISHIVAL	Other	840	38.2	12.8%	—	0.18	+36.0%
KHAICHEM	Other	594	8.2	27.1%	—	1.07	+33.7%
MWL	Other	824	19.5	15.3%	—	0.79	+29.8%
DALMIASUG	Other	3,130	8.9	10.9%	—	0.17	+29.2%
DELPHIFX	Other	4,604	69.1	2.2%	—	25.47	+28.4%
CYIENTDLM	Other	2,728	33.2	8.3%	—	0.21	+27.5%
KECL	Other	956	89.8	8.5%	—	0.83	+26.4%
MANALIPETC	Other	948	8.5	9.7%	—	0.14	+26.0%
BODALCHEM	Other	860	28.4	2.7%	—	0.77	+25.1%

How to read this screen

Small-caps (₹500 Cr to ₹5,000 Cr) are where multi-bagger potential lives — but so does 90%+ drawdown risk. Filtering for both revenue acceleration (25%+ YoY) and profit growth (10%+ YoY) screens out the top-line-only 'story' small-caps. Still: every name here warrants at least a 2-hour deep-dive before you size into it.

Refine these filters →

Explore other screener presets

High ROCE · low debt →

Indian companies delivering ROCE above 20% with debt-to-equity below 0.5 — quality compounders that make money without leverage. Filtered live from NSE/BSE XBRL filings. Free, no signup.

Value large-caps →

Large-cap Indian stocks (market cap > ₹50,000 Cr) trading under P/E 15 with ROE above 15% — the classic value-at-scale screen. Data from NSE/BSE public filings, refreshed daily.

Debt-free growth →

Indian stocks with debt-to-equity below 0.1 and revenue YoY growth above 20% — growth compounders that fund expansion from internal accruals, not borrowings. Live from XBRL filings.

High ROE compounders →

Indian stocks with ROE above 18% and positive revenue growth — the Buffett-style quality-compounder screen. Applied to the full NSE/BSE universe, refreshed daily.

Mid-cap value →

Mid-cap Indian stocks (₹5,000–50,000 Cr) trading below P/E 20 with ROE above 15% — the sweet-spot universe where large-cap stability meets small-cap growth without either's extremes.

Consistent profit growers →

Indian stocks with profit YoY growth above 25% and revenue growth above 15% — operational-leverage compounders where the bottom line grows faster than the top.

ASK AXEL

Want this screen explained, or refined with a qualitative layer?

Ask Axel to narrate the small-cap growth screen — sector-by-sector, pointing out the names with management quality flags, regulatory exposure, or thesis risk the pure-numbers filter can't see.

Ask Axel free

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Screener output is a data-driven filter of publicly-disclosed NSE/BSE XBRL financials. Not investment advice. Filter criteria reflect the quantitative rules specified; they do not encapsulate company-specific risks, management quality, sector cyclicality, forward prospects, or material non-public information. Always combine with qualitative research before any investment decision.